Skip to content

InMode Morpheus8

Save device

RF Microneedling · Fractional bipolar RF microneedling

Technology: RF Microneedling

Classification & configurations

Category group: Skin tightening & remodeling (RF microneedling, monopolar RF, HIFU)

Also sold as / variants: Morpheus8 Body, Morpheus8 Prime — applicator and configuration variants of the same platform, covered on this page.

Current

At a glance

New price
$40k–$120k depending on configuration
Configuration prices
  • standalone Morpheus8 console $40k–$60k
  • InMode multi-handpiece platform bundle $80k–$120k
Reported source: Dealer quote · Aug 12, 2026
Used asking price
$25k–$60k depending on configuration and hoursReported source: Used listing · Aug 12, 2026
FDA status
Supplies & recurring costs
See supply and replacement costs below.
View supply details
Sources and verified data on file

Data on file

Recurring consumables
Not verified
FDA
FDA ClearedK192695, K240017
Used asking prices
1 listing, latest Aug 12, 2026Used listing · Aug 12, 2026
  • This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
  • Bottle prices and estimates may still appear under Treatment & running costs.
  • The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.

Figures are reference points, not current offers. Used asking prices are not completed-sale values.

Latest price source dated: Aug 12, 2026 · Manufacturer-source documents checked: August 31, 2026

·FDA database · Updated Aug 12, 2026
Read FDA-cleared indicationsExact wording from 2 FDA records

K192695 (Inmode MD, Ltd., 2019)

The InMode System with the Morpheus8 (Fractora) Applicators is intended for use in Dermatologic and General Surgical procedures for Electrocoagulation and Hemostasis. At higher energy levels greater than 62 mJ/pin, use of the Morrpheus8 (Fractora) Applicator is limited to Skin Types I-IV.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K240017 (InMode, Ltd., 2024)

The InMode System with the Morpheus8 90 Applicator is intended for use in dermatological procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 90 Applicator is limited to Skin Types I-IV.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Page updated: September 19, 2026 · How we verify

New and used price references
New$40k–$120k
Reported source: Dealer quote · Aug 12, 2026
Used$25k–$60k
Reported source: Used listing · Aug 12, 2026

Axis runs $0–$120k. Reference figures, not current offers. Used asking prices are not completed-sale values.

Consumable cost per treatment

Not verified

We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.

Price sourcesSources, dates and configurations
New: $40k–$120k depending on configuration (standalone Morpheus8 console $40k–$60k; InMode multi-handpiece platform bundle $80k–$120k)Full InMode workstation with Morpheus8 applicator: $60k–$120k new; a Morpheus8 handpiece added to an existing InMode platform runs materially less — config matters, get the quote itemized.·Dealer quote · Updated Aug 12, 2026
Used asking range: $25k–$60k depending on configuration and hours·Used listing · Updated Aug 12, 2026
Key factsCompany, specifications and verification dates
Key facts
ManufacturerInMode
CompanyOwner: Publicly traded (NASDAQ: INMD; no single controlling owner) (public company, since 2019) · Distribution: direct
Parent companyInMode
Brand ownerInMode
Built by (OEM)InMode Ltd.
CategoryRF Microneedling
TechnologyFractional bipolar RF microneedling
FDA statusFDA Cleared
510(k) citationK192695, K240017
New price range$40k–$120k depending on configuration (standalone Morpheus8 console $40k–$60k; InMode multi-handpiece platform bundle $80k–$120k)
Used asking range$25k–$60k depending on configuration and hours
ConsumablesRFID single-use tips per treatment: 12-pin Prime, 24-pin, 40-pin Body and T-tip (K200947, K231790). Genuine tips are locked to your InMode account; InMode does not publish list tip pricing.
Launch year2019
Latest price source datedAug 12, 2026
Manufacturer-source documents checkedAugust 31, 2026

Overview

Alternatives to compare: Vivace Ultra, Potenza, Sylfirm X, Secret RF and Genius. Check the exact handpiece, intended treatments, consumables and training included in each quote.

How it worksTechnology and manufacturing

How the technology works

Bipolar fractional RF through arrays of coated pin electrodes; insulation along the shaft concentrates thermal energy at the tip, coagulating tissue at programmed depths while sparing the epidermis.

Tips span shallow resurfacing arrays through 24-pin face tips (to ~4mm) up to the 40-pin Body tip reaching ~7mm mechanical depth plus ~1mm thermal effect — deep enough to remodel subdermal fat, hence InMode's "adipose remodeling" positioning.

Burst mode fires RF sequentially at multiple depths in one insertion, treating a full tissue column per pass. Used for wrinkles, laxity, acne scarring, jawline/submental and body contouring adjuncts.

Patented technology

InMode's patent estate centers on coated/insulated pin-electrode design for depth-controlled subdermal coagulation and the multi-depth Burst sequence. The 2024 Morpheus8 90 clearance added the category's first cleared soft-tissue-contraction indication — a genuine regulatory differentiator.

Origin

Designed and manufactured in Israel by InMode Ltd. (Yokneam) — one of the few major RF-MN platforms that is not a Korean OEM product.

FDA & regulatory detailClearance timeline, authorization route and citation notes

Source and verification notes

·FDA database · Updated Aug 12, 2026Clearance K192695; K240017
Documented clearance timeline
Documented dates: Launch 2019, Clearance 2023, Clearance 2024201920232024

Launch 2019 · Clearance 2023 · Clearance 2024 · K192695; K240017

Authorized via 510(k)

FDA-cleared indications (verbatim)

K192695 (Inmode MD, Ltd., 2019)

The InMode System with the Morpheus8 (Fractora) Applicators is intended for use in Dermatologic and General Surgical procedures for Electrocoagulation and Hemostasis. At higher energy levels greater than 62 mJ/pin, use of the Morrpheus8 (Fractora) Applicator is limited to Skin Types I-IV.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K240017 (InMode, Ltd., 2024)

The InMode System with the Morpheus8 90 Applicator is intended for use in dermatological procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 90 Applicator is limited to Skin Types I-IV.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Marketed for

RF Microneedling — Fractional bipolar RF microneedling

Marketing claims are the manufacturer's own and are not the same as a cleared indication.

510(k) numbers

K192695, K240017

Regulatory timeline

  • K192695 (2019) — InMode System with Morpheus8 and Fractora applicators — the platform/predicate clearance.
  • K200947 (2020) — Morpheus8-specific clearance.
  • K231790 (2023) — Later modification to the cleared device.
  • K240017 (2024) — Morpheus8 90 applicator, soft-tissue contraction — the first-in-category claim.

Parent company: InMode

Legal manufacturer: InMode Ltd. (Israel)

Applicant on the FDA record

Inmode MD, Ltd.The applicant named on the FDA record can differ from the brand shown on the device.

Clearance notes

K192695 — cleared for electrocoagulation and hemostasis in dermatologic and general surgical use (energy-per-pin limits by skin type). 2024 clearances (including Morpheus8 90) added the first fractional-RF soft-tissue-contraction claim in the category.

Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.

FDA safety actions

Recorded recalls, warning letters and safety communications. Terminated actions remain visible as history.

How we report safety actions

Checked 7 Sep 2026 against FDA enforcement data dated 2 Sep 2026.

  • FDA safety communicationFDA safety communication, issued 15 October 2025Open

    Initiated Oct 15, 2025

    Scope as FDA lists it

    Applies to RF microneedling devices used for dermatologic or aesthetic procedures intended to improve the appearance of the skin. FDA is aware of reports of burns, scarring, fat loss, disfigurement and nerve damage, and of injuries needing surgical repair.

    FDA advises providers to discuss these risks with patients and to report complications.

    Reason and action

    FDA advises providers to discuss these risks with patients before treatment, to use devices only as cleared, and to report complications to MedWatch. FDA did not name individual brands; the communication covers 510(k)-cleared RF microneedling devices as a class.

    This communication applies to a class of devices, not to a specific unit or recall.

    This is an FDA communication about a device class, not a recall of specific units; read the FDA notice for the reported risks and FDA's recommendations.

    Manufacturer response: none on file — manufacturers can reply via their company profile.

    FDA record

Look-alike devices

Comparing an unbranded RF microneedling unit? Check the exact model rather than relying on similar photos or treatment claims.

Listed manufacturer for this profile: InMode Ltd.

  • FDA record: Match any claimed 510(k) or De Novo number to the exact model and applicant in the FDA database.
  • Support: Get written warranty, training, consumables and service terms from the seller.
  • Financing: Confirm availability for the exact unit before including it in your budget.

We do not profile these unbranded units or verify their support and financing terms. This profile’s FDA record applies to the named device, not every similar-looking unit.

What we publish about legal and safety matters

Treatment & running costs

Treatments

Sessions & timing

No treatment schedule documented yet.

What practices charge

No sourced treatment price on file.

Use the price you expect to collect for your planned treatment menu, after package discounts. Include tips, staff time, service and equipment payments when estimating contribution per session.

Supplies & recurring costs

RFID single-use tips per treatment: 12-pin Prime, 24-pin, 40-pin Body and T-tip (K200947, K231790). Genuine tips are locked to your InMode account; InMode does not publish list tip pricing.

·Dealer quote · Updated Aug 31, 2026

Annual service & support

No annual service cost documented yet.

Payback calculatorModel your own volume, labor and service costs

Estimate your payback

Pre-filled from our published InMode Morpheus8 data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.

Start from

No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.

Pre-filled from the midpoint of the published new-price range

20 is an illustrative default — change it to your volume.

No sourced per-session price on file — enter what you charge.

Required — enter your cost; missing data does not mean $0.

Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.

Annual service contract ÷ 12, if you carry one.

Your estimate

Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.

This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.

ComplianceScreening and contraindications on the manufacturer's record

Contraindications & screening

Pacemakers/ICDs and implanted electronics, pregnancy, active infection, recent isotretinoin, keloid tendency, metal implants in the field, uncontrolled diabetes; darker skin types require conservative energy-per-pin per the clearance, and overdriven deep treatments carry documented risks of fat atrophy, grid marking, and PIH.

Warranty & serviceWhat to confirm in writing before you buy

Before buying new or used, confirm in writing:

  • Current warranty coverage
  • Included training
  • Service terms

Chains using this device

A chain listing does not establish availability at every location.

  • Next Health

    Longevity & wellness

    Service pages

    Reported
  • VIO Med Spa

    Medspa franchise

    Chain treatment menu

    Confirmed
  • Formula Wellness

    Wellness franchise

    Service pages

    Reported

Owner & operator reviews

Write a review

No owner or operator reviews yet. Be the first →

Current alternatives

Current catalog models to research. Confirm availability and configuration with the supplier.

Agnes RF

RF Microneedling · $30k–$50k

Cartessa VirtueRF

RF Microneedling

History8 tracked changes

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. September 19, 2026

    Economics and overview evidence

    Replaced unsupported treatment-price, margin or comparative assertions in economics and overview prose with neutral quote-planning guidance. No purchase prices, source records, review scores, model status or verification dates changed. Full earlier wording is retained in this database correction record; the public history shows this summary.

    Source: Catalog update

  2. September 7, 2026

    notes

    Source: Catalog update — editorial sentences removed (neutral-voice standard, 7 Sep 2026)

  3. September 4, 2026

    Warranty & service

    Unsourced evaluative sentence removed under the opinion-layer gate.

    Source: Catalog update — Wave D opinion-layer gate, 2026-09-04

  4. September 4, 2026

    Warranty & service

    Source: Editorial sweep 2026-09-04: unsourced opinion removed

  5. September 4, 2026

    FDA indication

    Source: Catalog update

  6. September 1, 2026

    Used price range

    $30k–$60k$25k–$60k depending on configuration and hours

    Source: Catalog update

  7. September 1, 2026

    New price range

    Source: Catalog update

  8. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Cite this data: The Aesthetic Index, "InMode Morpheus8 — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).

Get the full State of Aesthetic Devices 2026 report

A catalog of US-marketed aesthetic and wellness devices — preview it free.

Get the report

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.